Gibson Neil W 4

What Happened

• Neil W. Gibson, a director of Instil Bio, received a derivative award (stock option grant) reported on 2026-06-11. The Form 4 records the grant as 0 shares at $0.00 (derivative), indicating an option award rather than an immediate share purchase or cash transaction. No immediate cash value or shares were delivered.

Key Details

• Transaction date: 2026-06-11; filing date (Form 4): 2026-06-12 (timely).
• Reported amount: 0 shares at $0.00 (derivative option grant).
• Ownership after transaction: not specified in the Form 4 (filing records the grant as a derivative award).
• Footnote: The option vests in 12 substantially equal monthly installments beginning July 11, 2026, subject to continuous service. Any unvested portion not vested by the next annual stockholder meeting will vest in full; the option also vests in full upon the reporting person’s death, Disability, or a Change in Control (per the Plan).

Context

• This is a compensation/award grant (not a market buy or sale). Such grants are common for directors and do not by themselves indicate a buy/sell signal. The Form 4 records the derivative award; exercise price, underlying share count (if any), or additional grant terms beyond the vesting language may be described in the company’s grant agreement or other disclosures.